During Tuesday’s Afternoon trade, Shares of Yamana Gold Inc. (USA) (NYSE:AUY), gained 8.33% to $2.14.
Yamana Gold Inc., will release its third quarter 2015 results after market close on October 29, 2015 followed by a conference call and webcast on October 30, 2015 at 9:00 a.m. ET.
Yamana Gold Inc. engages in gold mining and related activities, counting exploration, extraction, processing, and reclamation. The company has precious metal properties and land positions in the Americas.
Shares of Staples, Inc. (NASDAQ:SPLS), inclined 0.73% to $34.70, during its current trading session.
Staples (SPLS) makes more for less happen this holiday season with great deals in stores, online and via mobile. Staples.com will feature amazing deals on Thanksgiving Day, giving customers the convenience of shopping from home while stores are closed. Deals in stores start at 6 a.m. on Black Friday, and Staples.com deals continue through Cyber Monday.
Staples customers won’t have to wait until the week of Black Friday for great deals. Starting in early November, Staples will offer special holiday savings both in store and online on a huge assortment of the latest tech devices and other essential products that businesses need as well as easy-to-create, personalized gifts from Staples Copy and Print, many with same-day pick-up options.
On other hand, Equity analysts at the Brokerage firm Citigroup maintains its rating on Staples, Inc. (NASDAQ:SPLS). The rating major has initiated the coverage with an neutral rating on the shares. The Analysts at Citigroup lowers the price target from $18 per share to $15 per share. The rating by the firm was issued on August 24, 2015.
Staples, Inc., together with its auxiliaries, operates office products superstores. It operates through three segments: North American Stores & Online, North American Commercial, and International Operations.
Shares of Amgen, Inc. (NASDAQ:AMGN), dipped -2.01%, and is now trading at $140.93.
Amgen, will present at the Barclays Biosimilars Symposium at 8 a.m. ET on Wednesday, Oct. 7, 2015, in New York City. Scott Foraker, vice president and general manager of Biosimilars at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen’s website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen’s website for at least 90 days following the event.
On other hand, Amgen (AMGN) has been given an “A” credit rating by Morningstar. The investment research firm’s “A” rating indicates that the company is a low default risk. They also gave their stock a five star rating.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.
Finally, Shares of Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), gained 2.55%, and is now trading at $1.40.
Ballard Power Systems, declared that the Company’s acquisition of Protonex Technology Corporation has closed. As consideration for the transaction, Ballard is assuming and paying certain of Protonex’s debt obligations and transaction costs of about $4.0 million and is paying the remaining consideration through the issuance of about 11.4 million Ballard shares.
On other hand, Rodman & Renshaw reissued their buy rating on shares of Ballard Power Systems (BLDP) in a research note published on Monday morning, Market Beat Ratings reports.
Ballard Power Systems Inc. engages in the development and commercialization of proton exchange membrane fuel cells worldwide. The company is primarily involved in the design, development, manufacture, sale, and service of fuel cell stacks, modules, and systems for various applications.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
